Etanercept, methotrexate: genetic variation determines response in RA

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1463, 2004-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stellar results for etanercept + methotrexate in RA

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Etanercept plus methotrexate slows the TEMPO of RA progression

By  

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Etanercept plus methotrexate is associated with improved clinical outcomes in patients with rheumatoid arthritis (RA) regardless of disease duration

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Infliximab, etanercept in RA discussed

By  

Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Genetic cause of diabetes determines drug response

By  

Inpharma, Vol. 1, Iss. 1410, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite